Skip to main content

Table 3 Best fitting simple linear regression predictors of renal impairment in cirrhotic patients

From: Do old urinary biomarkers have a place in the new definition of hepatorenal syndrome in the Egyptian cirrhotic patients? A single-center experience

Variable

OR

95% CI

P-Value

Age (years)

1.2

1.09–1.31

< 0.001*

Length of hospital stay (days)

1.83

1.37–2.44

< 0.001*

Encephalopathy (n, %)

21

5.51–79.99

< 0.001*

Spontaneous bacterial peritonitis (n, %)

6.71

1.65–27.34

0.008*

Total bilirubin (mg/dl)

1.44

1.11–1.87

0.006*

Direct bilirubin (mg/dl)

1.66

1.15–2.41

0.007*

INR

4.49

1.55–13

0.006*

CPT score

2.58

1.69–3.95

< 0.001*

CPT class (n, %)

 B

1

  

 C

12.6

2.62–60.54

< 0.001*

MELD score

1.89

1.37–2.62

< 0.001*

MELD NA score

1.87

1.39–2.5

< 0.001*

Urea (mg/dl)

1.007

1.001–1.012

0.013*

Creatinine (mg/dl)

1.64

1.17–2.32

0.005*

NGAL (pg/ml)

1.003

1.001–1.005

0.001*

KIM (pg/ml)

1.4

1.12–1.76

0.003*

IL 18 (pg/ml)

1.05

1.01–1.09

0.010*

SOFA score

2.83

1.78–4.49

< 0.001*

APACHE II score

1.82

1.39–2.38

< 0.001*

FENa(%)

6.96

1.61–30.12

0.009*

  1. *Significant level at P value < 0.05
  2. Bold values indicate significant results
  3. INR International normalized ratio, CPT Child-Turcotte-Pugh score, MELD Model for end-stage liver disease, MELD-Na Model for end-stage liver disease-sodium, FENa Fractional excretion of sodium, SOFA score Sequential Organ Failure Assessment, APACHE II score Acute Physiology and Chronic Health Evaluation II score